PEth Quantification via GC-MS Derivatization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying phosphatidylethanol (PEth) in blood samples using liquid chromatography/mass spectrometry have sub-optimal sensitivity and are unable to detect decomposed PEth, making them ineffective for diagnosing chronic alcohol abuse and detecting PEth in postmortem samples.
Innovation Solution
A method involving extraction of PEth from blood samples using a solvent mixture of chloroform and an alcohol with 1-4 carbon atoms, followed by concentration and derivatization with a silylating agent, allowing for detection of intact and decomposed PEth using gas chromatography mass spectrometry (GC-MS).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If liquid chromatography/mass spectrometry is used to detect a single PEth species, then the method is simple to operate, but the sensitivity is sub-optimal and decomposed PEth cannot be detected
Solution Approach 1:
The patent changes the detection parameter from monitoring a single PEth species at specific retention times to monitoring multiple PEth homologs across a range of retention times. This parameter change enables detection of both intact and decomposed PEth, significantly improving sensitivity and measurement precision without requiring complex additional equipment
Solution Approach 2:
The GC-MS method is designed to universally detect all PEth homologs (including intact and decomposed forms) through a single analytical platform. By using multiple reaction monitoring (MRM) transitions and scanning across a retention time range, the method achieves multi-functionality in detecting various PEth species, thereby improving sensitivity comprehensively
2Quantity of substance
If current LC-MS methods measure only one PEth species, then the analysis is fast, but only 35-40% of total PEth is detected
Solution Approach 1:
The patent performs preliminary derivatization of PEth compounds before GC-MS analysis to convert them into volatile derivatives suitable for gas chromatography. This preliminary action enables subsequent detection of multiple PEth homologs including decomposed forms, increasing total PEth detection to over 90% while maintaining efficient analysis through optimized MRM transitions
3Reliability
If traditional methods are used, then the procedure is simple, but decomposed PEth cannot be detected making them ineffective for postmortem samples
Solution Approach 1:
The patent changes the detection approach by monitoring multiple PEth homologs across a retention time range (8-14 minutes) rather than a single species. This parameter change enables detection of decomposed PEth forms that result from olefin oxidation, fatty acid hydrolysis, or glyceryl residue hydrolysis, significantly improving reliability for chronic alcohol abuse diagnosis and postmortem sample analysis
Solution Approach 2:
The patent uses derivatization reagents as intermediaries to convert non-volatile PEth compounds into volatile derivatives suitable for GC-MS analysis. This intermediary step preserves the structural information of both intact and decomposed PEth, enabling reliable detection in postmortem samples where decomposition has already occurred
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances sensitivity by detecting all PEth homologs, providing more reliable and reproducible results, especially for chronic alcohol abusers and postmortem samples, and allows for real-time bedside care.
Implementation Method 1
extracting PEth from the blood sample by contacting the blood sample with a solvent comprising one or more of chloroform and an alcohol having 1-4 carbon atoms
Implementation Method 2
derivatizing the PEth in the PEth concentrate with a derivatizing agent to form a single PEth derivative
Data Source
AI summary
Disclosed herein is a method for quantifying phosphatidylethanol (“PEth”), a direct ethanol biomarker, from a blood sample using gas chromatography mass spectrometry. The method disclosed herein is useful for diagnosing acute and chronic alcohol abuse.